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Abstract.  Cultured smooth muscle cells (SMC) un- 
dergo induction of smooth muscle (SM) alpha actin at 
confluency. Since confluent cells exhibit contact inhibi- 
tion of growth,  this finding  suggests that induction of 
SM alpha actin may be associated with cell cycle with- 
drawal.  This issue was further examined in the present 
study using fluorescence-activated cell sorting of SMC 
undergoing  induction at confluency and by examination 
of the effects of FBS and platelet-derived growth factor 
(PDGF) on SM alpha actin expression in postconfluent 
SMC cultures that had already undergone induction. 
Cell sorting was based on DNA content or differential 
incorporation  of bromodeoxyuridine (Budr).  The frac- 
tional  synthesis of SM alpha actin  in confluent cells 
was increased two- to threefold compared with sub- 
confluent log phase cells, but no differences were ob- 
served between confluent cycling (Budr  +) and noncy- 
cling (Budr-) cells.  In cultures not exposed to Budr, 
confluent cycling S  +  G2 cells exhibited similar induc- 
tion.  These data indicate that cell cycle withdrawal is 
not a prerequisite for the induction of SM alpha actin 
synthesis in SMC at confluency. Growth stimulation  of 
postconfluent cultures with either FBS or PDGF re- 
sulted in marked repression of SM alpha actin synthe- 
sis but the level of repression was not directly related 
to entry into S phase in that PDGF was a more potent 
repressor of SM alpha actin  synthesis than was FBS 
despite a  lesser mitogenic effect. This differential effect 
of FBS versus PDGF did not appear to be due to 
transforming growth factor-beta present in FBS since 
addition of transforming growth factor-beta had no 
effect on PDGF-induced repression.  Likewise, FBS 
(0.1-10.0%)  failed to inhibit PDGF-induced repression. 
Taken  together these data demonstrate that factors 
other than replicative frequency govern differentiation 
of cultured SMC and suggest that an important func- 
tion of potent growth factors such as PDGF may be 
the repression of muscle-specific characteristics. 
T 
HE abnormal growth of vascular smooth muscle cells 
(SMC) t is an important  feature of atherosclerosis  and 
hypertension and, as such, has been the subject of vig- 
orous investigation.  A body of evidence now exists which 
suggests  that  the state of differentiation  of smooth muscle 
(SM) influences  its growth responsiveness  and that the loss 
of proliferative  suppressor mechanisms  associated with dif- 
ferentiation and maturation,  rather than just stimulation with 
positive regulators  of cell growth,  may comprise an impor- 
tant component of SMC growth control (Chamley-Campbell 
et al.,  1979, 1981; Schwartz et al.,  1986).  It is well estab- 
lished that the expression of SMC differentiated characteris- 
tics are altered in intimal thickenings and in the atherosclero- 
tic lesions of man and animals  (Gabbiani et al., 1981, 1984; 
Kocher et al.,  1984; Mosse et al.,  1985).  Lesion cells ex- 
hibit,  among other changes,  a reduction in SM-specific ac- 
1.  Abbreviations  used  in  this paper:  Budr,  bromodeoxyuridine; PDGE 
platelet-derived  growth  factor;  SFM,  serum-free medium;  SM,  smooth 
muscle; SMC,  smooth muscle cells; TGF-[~, transforming growth  factor- 
beta. 
tins  and  alterations  in the expression  of intermediate  fila- 
ments (Gabbiani  et al.,  1981, 1984; Kocher et al.,  1984). 
However, whether these changes in differentiated state of SM 
are a prerequisite  for cell proliferation  as has been proposed 
by Chamley-Campbell  et al.  (1979, 1981) is controversial. 
The development of in vitro systems  for studying  SMC 
differentiation,  as well as the identification  of SM-specific 
proteins for use as markers of differentiation,  have facilitated 
closer examination  of the relationship  between growth and 
differentiation  in SMC.  Several  investigators  have demon- 
strated that serially  subpassaged  arterial  SMC express SM- 
specific  contractile  proteins in vitro (Franke  et al.,  1980; 
Larsen  et  al.,  1984; Owens et al.,  1986;  Rovner  et al., 
1986). Owens et al. (1986) have characterized  the expression 
of SM alpha actin in cells cultured  from rat thoracic aortic 
media  and  reported  an  inverse  relationship  between cell 
proliferation  and SM alpha actin expression.  Complete loss 
of SM alpha actin did not appear to be required for the onset 
of DNA synthesis in primary cultures.  However, both SM al- 
pha actin content and synthesis were threefold higher in post- 
confluent  cultures than  in log phase cells.  Alpha actin  ex- 
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fluent cells in a serum-free medium (SFM), but only after 
extended periods of growth arrest. Strauch and Rubenstein 
(1984) have reported a similar induction of alpha actin syn- 
thesis in postconfluent growth-arrested BC~H1 cells, a SMC- 
like line derived from mouse brain tumour.  Additionally, 
Rovner et al. (1986) demonstrated the expression of two SM- 
specific myosin heavy chains in contact-inhibited postcon- 
fluent but not in logarithmically dividing subconfluent rat 
aortic SMC. 
While these data appear to establish an important relation- 
ship between growth and cytodifferentiation in vascular SMC, 
they also leave important issues unresolved. For example, 
the density induced expression of SM-specific contractile 
proteins may not result directly from cell cycle withdrawal 
but may merely occur concomitantly. One possibility is that 
cellular changes resulting from cell-to-cell contact at con- 
fuency rather than contact inhibition of growth may be re- 
sponsible for the induction of SM-specific proteins. This is 
an issue of broad interest in the field of cell biology but is 
very poorly understood, in part because of a lack of appro- 
priate cell culture models and an inability to dissociate the 
effects of cell-cell contact from contact inhibition of growth. 
In the present study we have explored the effects of cell cy- 
cle status  versus cell density on control of SM alpha actin 
expression by SMC by: (a) using fluorescence-activated cell 
sorting to determine whether withdrawal from the cell cycle 
is a prerequisite for the induction of SM alpha actin in cul- 
tured SMC at confluence, and (b) examining the effects of 
mitogenic stimulation of postconfluent SMC on expression 
of SM alpha actin. 
Materials and Methods 
Cell Culture 
Smooth muscle cells were isolated from rat thoracic aorta and cultured by 
a modification of the methods of Owens et al. (1986)  as reported by' Gei- 
sterfer et al. (1988).  Ceils were plated at an initial seeding density of 3,500 
cells/cm  ~ in 75-cm  2 tissue culture flasks (Corning Glass Works, Corning, 
NY) and grown to confluence in Medium-199 (Gibco, Grand Island, NY) 
containing 10% FBS (Hyclone Laboratories, Logan, UT),  100 U/ml peni- 
cillin, and lOO lag/ml streptomycin. All SMC cultures used in these studies 
were of passage number 13 or less. 
Cell Sorting 
When cultures were confluent as assessed by phase microscopy, they were 
treated with bromodeoxyuridine (Budr;  10  -4 M; Sigma Chemical Co., St. 
Louis, MO) or Budr vehicle for 28 h in the dark. The 28-h Budr-labeling 
period is approximately 1.4 cell cycle times and permits all cells that cycle 
at any time during the experiment to incorporate the label. At the time of 
the Budr pulse, replicate flasks were pulsed with [35S}methionine (40 ~Ci/ 
ml, >800 Ci/mmol; New England Nuclear, Boston, MA) for either the first 
14 h (i.e., 14-28 h before harvest followed by a chase with an excess of unla- 
beled I mM L-methionine tbr 14 h) or the 14 h immediately before harvest. 
Samples intended for sorting on the basis of DNA  content were not 
treated with Budr and received [35Slmethionine  (80 I.tCi/ml) for 4 h before 
harvest. Log phase cultures were treated similarly but were harvested while 
subconfluent. 
After  Budr  and  methionine  pulses,  cells  were  harvested  in  trypsin 
(0.05 %; Gibco) and ethylenediaminetetraacetate (0.02 %; Sigma Chemical 
Co.), collected in 50-ml centrifuge tubes containing 1.0 ml FBS, washed in 
PBS, and fixed in 8 vol of 100% methanol at4°C for 15 min. Fixed samples 
were then resedimented and suspended in Hoechst 33258  (0.58  ~tg/ml in 
PBS; Sigma Chemical Co.) immediately before sorting. Stained SMC were 
sorted on  a  Epics  V  Fluorescence-Activated Cell  Sorter (Coulter Elec- 
tronics, Inc., Hialeah, FL) using a Coherent 90-5 argon ion laser with UV 
enhancement. The fluorochrome was excited at 351-363  nm and the emis- 
sion screened by a 475-nm-long pass and UV laser block filters.  Though 
the actual  number of cells  sorted  into cell  cycle subpopulations varied 
greatly between experiments, the lowest number collected in any subpopula- 
tion was approximately 400,000.  Generally,  between 0.5  and  1.5  x  106 
cells were collected in Budr ~ or S  +  G.~ populations, while the quantity of 
Gt  and Budr- cells was usually much higher (2-5  ×  106). The purity of 
sorted subpopulations was >99% as assessed by reassaying sorted popula- 
tions in a  limited number of cases.  After collection in  15  ml centrifuge 
tubes, sorted cells were centrifuged, the supernatant discarded, and the pel- 
let  lysed and  sonicated in  an  IEF  buffer containing  1%  SDS  (Bio-Rad 
Laboratories,  Richmond, CA),  10%  glycerol, and 20 mM dithiothreitol 
(Sigma Chemical Co.) at a  final  concentration of approximately 5  ×  106 
cells/ml, 
Growth Factor Studies 
SMC were plated at 3,500  cells/cm  2 in medium containing  10%  FBS in 
duplicate 60-mm petri dishes and replicate 24-well culture plates and grown 
until confluent. At confluency, medium was removed, cells were rinsed, and 
the cultures incubated with SFM containing equa!  parts of DME (Gibco) 
and Ham's FI2 (Gibco) supplemented with insulin (1 ~VI; Sigma Chemical 
Co.),  transferrin (5  ~g/ml;  Sigma Chemical  Co.),  ascorbate (0.2  mM; 
Sigma Chemical Co.), penicillin (100 U/ml; Gibco), and streptomycin (t00 
p.g/ml; Gibco) for 5 additional days. This SFM formulation has been shown 
to  maintain  cultured  SMC  in  an  anabolic,  quiescent  state  (Libby  and 
O'Brien,  1983)  and to maintain high levels of SM alpha actin expression 
in these cells (Owens et al.,  1986). 
After 5 d in SFM, the media was replaced and cultures were treated with 
appropriate mitogens: partially purified human PDGF ("-,0.4% pure; Raines 
and Ross,  1985),  phenyl-Sepharose-purified PDGF (>95%  pure; Raines 
and Ross, 1982) (both PDGF preparations were generously supplied by Dr. 
Russell Ross, University of Washington, Seattle, WA),  PDGF vehicle (10 
mM acetic acid in 2 mg/ml BSA), FBS, HPLC-purified transforming growth 
fac:tor-beta (TGF-t3) (supplied by Dr, Akira Komoriya, Rorer Biotech Inc., 
Rockville, MD), or TGF-13 vehicle (1 mg/ml BSA) for 24 h, Parallel cultures 
were pulsed with either [3H]thymidine  (0.1 laCi/ml, 6.7 Ci/mmol; New En- 
gland Nuclear) for 24  h or [3SSlmethionine  (40 t.tCi/ml)  for 6  h  before 
harvest. 
FH]Thymidine Autoradiography 
Mu/tiwell plate cultures of SMC exposed to [-~H]thymidine were washed 
with PBS, fixed in 2% glutaraldehyde in PBS for 5 min, rewashed in PBS, 
dehydrated in 100% methanol, and processed for autoradiography as previ- 
ously described (Owens et al.,  1986).  Labeling indices were determined by 
scoring at least 4,000 cells from quadruplicate titer wells. 
Actin Isoform Synthesis 
Actin isoforms were resolved by two-dimensional IEF/SDS-PAGE via a 
modification of the technique of O'Farrell (1975) as described by Fatigati 
and  Murphy (1984)  and Owens et al.  (1986).  Densitometric analysis of 
Coomassie Brilliant Blue-stained gels yielded linear results over the protein 
loading range used and a coefficient of variation for alpha actia of 8.4%. 
In these studies, IEF gels were loaded with 50,000-150,000  cpm of celt ly- 
sate per lane. Control studies (data not shown) demonstrated that methanol 
fixation of cells does not affect the determination of fractional SM alpha ac- 
tin synthesis by two-dimensional IEF/SDS gel electrophoresis. 
Determination of fractional isoactin synthesis was made on developed au- 
toradiographs after exposure of dried gels to Kodak X-Omat K film for 1-10 d. 
Resultant images were digitized using an Eikonix 78/99 Digital Camera (512 
x  512 pixel resolution). Determinations of integrated optical density were 
obtained  using  a  Gould  IP8500  Image  Processor  (Freemont,  CA)  by 
defining the spot area with an appropriate cursor outline; background den- 
sity calculated on a pixel by pixel basis was determined in several adjacent 
areas  and  automatically  subtracted.  Values obtained  from  multiple  ex- 
posures of each gel were routinely analyzed and compared to ensure opera- 
tion within the linear range of the film. In addition, although the limited 
yields from sorting prohibited multiple determinations on all samples, this 
was done where possible. 
Statistics 
Fractional SM alpha actin synthesis values from sorted cell subpopulations 
were compared with that of log phase cells using the paired t test. Relevant 
comparisons within experiments (Budr  ~- vs.  Budr-; S  +  G~ vs.  G~) were 
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Figure 1. Representative flow cytometric DNA histograms of con- 
trol and Budr-treated rat aortic SMC at confluency. Rat aortic SMC 
were plated at an initial seeding density of 3,500 ceils/cm-' in 75- 
cm  2 culture  flasks and grown until cells  were just confluent.  At 
this time cultures were pulsed with vehicle or Budr (10  -4 M) in the 
dark for 28 h. Cells were then harvested in trypsin,  washed, fixed 
in 100% methanol,  stained with Hoechst 33258, and sorted in an 
Epics V Fluorescence  Activated Cell Sorter on the basis of either 
DNA content (A) or differential incorporation of Budr (B). Sorting 
of cell cycle subpopulations was carried out using gating windows 
similar to those depicted. The incorporation of Budr into the DNA 
of cycling cells results in a quenching of Hoechst 33258 fluores- 
cence. Thus the fluorescence of cells which have synthesized DNA,, 
i.e., cycling cells, is shifted to the left on the flow cytometric DNA 
histogram. 
also conducted using paired t  test.  Mean thymidine-labeling indices and 
fractional SM alpha actin synthesis values from growth factor-stimulated 
cultures were first compared using analysis of variance. When analysis of 
variance led to rejection of the omnibus null hypothesis means were further 
compared  using the  Newman-Keuls test  for  multiple comparisons.  All 
differences were considered statistically significant at P  <  0.05 level. 
Results 
Fluorescence Activated Cell Sorting 
Representative flow cytometric DNA histograms of control 
and Budr-treated rat aortic SMC at confluence are depicted 
in Fig.  1. When incorporated into the DNA of cycling cells, 
Budr results in a quenching of Hoechst 33258 fluorescence. 
Thus, the fluorescence of cells that have synthesized DNA 
during the 28-h Budr pulse (i.e., cycling cells) is shifted to 
the left on the flow cytometric DNA histogram. The follow- 
ing lines of evidence indicate that the rat aortic SMC used 
in these studies undergo only one additional cell doubling 
upon reaching confluency:  (a) multiple Budr substitutions 
are not observed if Budr-labeling periods are extended (data 
not shown) and thus Budr  + cells represent those cells com- 
pleting their final transit of the cell cycle, and (b) cell number 
approximately  doubles  after  establishment  of confluency 
(Owens et al.,  1986).  Additional experiments have demon- 
strated that cells which are Budr- do not undergo DNA syn- 
thesis if the labeling period is extended to 56 h. It is therefore 
reasonable  to  conclude  that  this  subpopulation  is  truly 
quiescent. 
It was also necessary to demonstrate that Budr itself ex- 
erted no effects on SM alpha actin expression under these ex- 
perimental  conditions.  Thus  we tested  the  effects of Budr 
(10  -4 M) on fractional alpha actin synthesis in unsorted cul- 
tures  undergoing  induction  at confluency.  Mean  fractional 
alpha actin synthesis values for treated and untreated cultures 
were 20.69  and 20.25 %, respectively. Statistical analysis of 
these data indicate that SM alpha actin synthesis is unaffected 
by treatment with  10  -4 M  Budr for 28 h  (P >  0.05,  paired 
t test). 
Fractional SM Alpha Actin Synthesis of Cycling 
and Noncycling Cells 
Fig.  2  presents  autoradiographs  of two-dimensional  SDS 
gels showing the fractional SM alpha actin synthesis of cul- 
tured SMC subpopulations sorted on the basis of DNA con- 
tent.  It should be noted that,  due  to the prolonged period 
required for sorting cell cycle subpopulations, charge modi- 
fications of actin were sometimes observed in two-dimen- 
sional IEF/SDS gels. However, by comparing actin isoform 
expression between unsorted cells and those subjected to ex- 
tended sorting we have found that resultant charge modifica- 
tions do not affect fractional isoactin synthesis determina- 
tions.  A summary of SM alpha actin synthesis values from 
densitometric analyses of autoradiographs is presented in Ta- 
ble I. Fractional beta and gamma actin values from sorted 
SMC  subpopulations are depicted in Tables II and III, re- 
spectively.  Results  demonstrate  that  confluent  cells  from 
these sorts were induced to express SM alpha actin irrespec- 
tive of their position in the cell cycle. Fractional SM alpha 
actin synthesis was two- to threefold greater in confluent cells 
than in subconfluent cells (P ~< 0.05)  in log phase growth but 
there were no significant differences in this parameter (ex- 
pressed as a percentage of log phase) between confluent cells 
in either G,  (227.9%)  or S  +  G2 (219.5%).  These results 
clearly demonstrate that SMC that continue to cycle as they 
reach confluency are induced to express alpha actin but do 
not provide comparison between definitively quiescent and 
cycling  subpopulations  since  cells  with  2C  DNA  content 
(i.e., sorted G~) are comprised of both quiescent Go and cy- 
cling  G,  cells.  Thus,  we also examined actin  isoform ex- 
pression of SMC sorted on the basis of differential incorpora- 
tion of Budr.  Results demonstrate (Fig.  3 and Table I) that 
both Budr  + (i.e., cycling cells) as well as Budr- (i.e., quies- 
cent cells) have undergone induction of SM alpha actin syn- 
thesis relative to that of log phase cells (P < 0.05), and exhibit 
fractional SM alpha actin synthesis of 254.2  and 290.8%, 
respectively, compared with log phase cells. 
To rule out the unlikely possibility that the induction of SM 
alpha actin synthesis occurs in subconfluent log phase S  + 
G2 cells as well as in confluent cycling cells, an additional 
experiment was performed in  which  log phase cells were 
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SDS gels showing the fractional  isoactin syn- 
thesis of cultured  SMC  subpopulations  sorted 
on  the  basis  of  DNA  content:  (a)  confluent 
G,;  (b)  confluent  S  +  G2;  (c)  confluent  un- 
sorted control; (d) unsorted  log phase culture. 
Fractional  isoactin synthesis of sorted cell pop- 
ulations  was determined by densitometric anal- 
ysis of autoradiographs  as described in Mate- 
rials and Methods. Note that confluent cells in 
the S and G2 phases of the cell cycle (b) have 
undergone induction  of SM alpha actin synthe- 
sis with respect to cells in log phase growth (d). 
Table 1. Fractional Alpha Actin Synthesis of SMC Sorted on the Basis of DNA Content or Differential 
Incorporation  of Budr* 
DNA 
Confluent  Log phase  0-14-h preharvest:~ 
Budr 
14-28-h preharvest§ 
Gj  227.9  ±  39.9  91.6  Budr  ÷  254.2  ±  30.6  192.8  ±  24.0 
n  =411  n  =  1  n  =4  n  =  3 
S  +  G_,  219.5  +  51.7  Undetectable  Budr-  290.8  ±  34.6  255.8  ±  48.7 
n=4  n=l  n=4  n=3 
Unsorted  276.2  ±  66.6  100.0  ±  6.1  Unsorted  247.7  +  36.5  212.6  ±  18.4 
n=3  n=5  n=4  n=3 
* Expressed as a percentage of log phase control;  data presented  as mean  _+  SEM. 
~: Cultures were pulsed with 135S]methionine during  the final  14 h of the 28-h Budr pulse. 
§ Cultures were pulsed with 135S]methionine during  the first  14 h of the 28-h Budr pulse. 
II n, number of independent experiments. 
Table 1I. Fractional Beta Actin Synthesis of SMC Sorted on the Basis of DNA Content or Differential 
Incorporation of Budr* 
DNA 
Confluent  Log phase  O-14-h preharvest¢ 
Budr 
14-28-h preharvest§ 
G~  56.67  +  3.15  62.83  Budr  ÷  55.12  ±  4.19  58.52  +  2.31 
n  =  411  n  =  1  n  =4  n  =  3 
S  +  G2  54.56  ±  4.20  65.77  Budr  50.56  ±  2.98  56.97  ±  4,41 
n=4  n=l  n=4  n=3 
Unsorted  50.14  ±  5.48  64.12  ±  0.80  Unsorted  52.95  ±  2.63  59.75  ±  1,58 
n=3  n=5  n=4  n=3 
* Data presented as mean  ±  SEM. 
:~ Cultures were pulsed with [~S]methionine during the final  14 h of the 28-h Budr pulse. 
§ Cultures  were pulsed with [~SSlmethionine during  the first  14 h of the 28-h Budr pulse. 
§ n, number of independent experiments~ 
sorted on the basis of DNA content. Fractional SM alpha ac- 
tin synthesis of sorted G, and S  +  G2 subpopulations was 
determined as above. Fractional SM alpha actin synthesis of 
log phase  G~  cells (91.6%  of unsorted log phase  control) 
was comparable to that of unsorted log phase cultures while 
fractional  SM  alpha  actin  synthesis of log  phase  S  +  G2 
cells was undetectable (Table I). These results eliminate the 
possibility that induction of SM alpha actin synthesis occurs 
in S  +  G2 phases of the cell cycle, irrespective of culture 
density. 
It  should  be  noted  that,  for the  purposes  of procuring 
sufficient quantities of cycling cells, it was necessary in this 
The Journal of Cell Biology,  Volume  107, 1988  302 Table IlL Fractional Gamma Actin Synthesis of  SMC Sorted on the Basis of  DNA Content or Differential 
Incorporation  of Budr* 
DNA  Budr 
Confluent  Log phase  O-14-h preharvest$  14-28-h preharvest§ 
Gi  19.38  ___  1.25  27.34  Budr  +  17.60  _+  2.44  20.79  5:2.63 
n  =411  n  =  1  n  =4  n=3 
S  +  G2  21.88  +  2.40  34.23  Budr-  17.74  +  3.00  15.57  +  1.23 
n=4  n=l  n=4  n=3 
Unsorted  20.23  _+  2.15  25.12  +  1.56  Unsorted  20.50  +_  3.33  17.43  ___  3.08 
n=3  n=5  n=4  n=3 
* Data presented as mean  +  SEM. 
$ Cultures were pulsed  with [35S]methionine during the final 14 h of the 28-h Budr pulse. 
§ Cultures were pulsed  with [35Slmethionine during the first  14 h of the Budr pulse. 
§ n, number of independent experiments. 
study to sort cells early in the induction process. The subjec- 
tive assessment of initial cell confluence by phase contrast 
microscopy undoubtedly contributed to high interexperiment 
variability in the degree of induction. Cultured SMC permit- 
ted to grow beyond this point underwent approximately one 
more doubling, reaching saturation density. The level of in- 
duction of SM alpha actin synthesis at saturation density is 
considerably higher than that reported in these studies for 
cells that had just reached confluency (Owens et al.,  1986). 
To examine whether levels of induction in cell cycle subpopu- 
lations  changed  with  time  after  initial  establishment  of 
confluency, the level of induction of  SM alpha actin was com- 
pared between SMC cultures which were pulse labeled with 
[35S]methionine  during  the  initial  14 h  of the 28-h Budr- 
labeling period and those labeled with [35S]methionine  dur- 
ing the latter 14 h of the Budr-labeling period. Induction of 
SM alpha actin synthesis was observed over both time inter- 
vals in both Budr  ÷ and Budr- cells, but the fractional SM 
alpha actin synthesis during the first half of Budr labeling 
was  significantly lower  in  Budr-  cells  (255.8%)  as  com- 
pared with that of Budr- cells labeled later in the induction 
process (290.8 %); P < 0.05; see Table I), indicating that in- 
creasing time of quiescence at confluence is associated with 
enhanced  expression  of SM  alpha  actin.  No  statistically 
significant differences were observed in Budr  ÷ or unsorted 
cells between the two pulse periods. 
Figure 3. Autoradiographs of two-di- 
mensional  SDS  gels  showing the 
fractional isoactin synthesis of cul- 
tured SMC subpopulations sorted on 
the basis of differential Budr incor- 
poration:  (a) Budr+; (b) Budr-;  (c) 
unsorted control.  Isoactin synthesis 
was  evaluated in  cultures  that  had 
been  pulsed  with [35S]methionine 
for 14 h before harvest. Results dem- 
onstrate that induction of SM alpha 
actin synthesis occurs in Budr  ÷ (cy- 
cling  cells)  relative  to  that  of log 
phase cells (see Fig. 2 d), as well as 
in  Budr-  (quiescent)  and  unsorted 
cells. 
Effects of  Mitogenic Stimulation on SM Alpha Actin 
Expression in Postconfluent SMC 
Since the preceding data strongly implicate a  role for cell 
density in the expression of SM alpha actin that may be inde- 
pendent of cell cycle status, it was of further interest to ask 
whether postconfluent, quiescent SMC could be mitogeni- 
cally stimulated, and if so, whether cell proliferation was as- 
sociated with repression of SM alpha actin synthesis under 
these conditions.  [3H]thymidine-labeling indices and  frac- 
tional SM alpha actin synthesis values of postconfluent SMC 
cultures exposed to FBS or PDGF are depicted in Fig.  4. 
(Autoradiographs  of  two-dimensional  IEF/SDS  gels  are 
shown in Fig. 5.) Both PDGF and FBS were mitogenic for 
postconfluent SMC in SFM (P <  0.05), stimulating 31 and 
61%  of the cells to undergo DNA  synthesis,  respectively. 
Significantly, FBS, which promotes mitogenesis in the ma- 
jority of cells was considerably less effective in repressing 
SM alpha actin synthesis (47%  decrease) than was PDGF 
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Figure 4. Effect of mitogens on S phase entry and SM alpha actin 
synthesis in  postconfluent quiescent  SMC  cultures.  SMC  were 
plated as above and grown to confluency in the presence of 10% 
FBS and then switched to serum-free medium for 5 d. At the end 
of this period cultures were treated with either PDGF, serum, or 
vehicle for 24 h: parallel cultures were pulsed with either [3H]thy- 
midine for 24 h or [35S]methionine  for 6 h before harvest. Cultures 
pulsed  with [3H]thymidine were  processed  for autoradiography 
and the thymidine indices determined. These studies were carried 
out using a partially purified preparation of PDGF (6 ng/ml, 0.4% 
purity; a gift from Dr. Russell Ross). (Solid bars) Fractional al- 
pha-actin  synthesis; (open bars) % [3H]thymidine-labeled  cells. 
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Figure 6.  Concentration dependence of PDGF effect on SM alpha 
actin synthesis (top) and S phase entry  (bottom).  Cultures were 
treated identically to those in Fig. 4 with the exception that a highly 
purified PDGF (0.t-10.0 ng/ml;  >95%  purity)  was used  in this 
study. 
Figure 5. Autoradiographs of two-dimensional IEF/SDS gels from 
SMC treated with PDGF or FBS as described in Fig. 4. 
To  exclude  the  possibility  that  the  observed  effects of 
PDGF could be attributed to a contaminant of the partially 
purified PDGF preparation, it was necessary to test a highly 
purified preparation of PDGF on SM alpha actin expression 
under identical experimental conditions.  Fig.  6 depicts the 
concentration dependence of both repression of SM alpha 
actin synthesis and [3H]thymidine-labeling index using phe- 
nyl-Sepharose-purified human PDGF (>95 % purity) from 
outdated human platelet-rich plasma (Raines and Ross,  1982). 
In this experiment, purified PDGF exhibited high potency 
and  efficacy in  repressing  alpha  actin  synthesis  (EDs0  = 
0.21 ng/ml) and stimulating S phase entry (EDs0 =  0.63 ng/ 
ml).  EDs0 values determined from an independent experi- 
ment  in  a  different SMC  line  were 0.90 and  1.74 ng/ml, 
respectively (data  not  shown).  Maximal  effects of PDGF 
were seen at a  PDGF concentration of 5  ng/ml which in- 
duced a 91% repression in fractional SM alpha actin synthe- 
sis and a 48-fold increase in the thymidine-labeling index. 
The differential effects of PDGF versus FBS on repression 
of SM alpha actin synthesis and mitogenesis (Figs.  4 and 5) 
could  be  due  to  factors  present  in  serum  which  inhibit 
mitogen-induced repression. To address this possibility we 
examined the ability of different concentrations of FBS to in- 
hibit PDGF-induced repression of SM alpha actin synthesis 
(Fig. 7). Again PDGF and FBS exhibited differential effects 
on repression of SM alpha actin synthesis and thymidine in- 
dices (P <  0.05).  However, co-treatment of SMC  cultures 
with FBS (0.1-10.0%)  and PDGF did not significantly affect 
the degree of mitogen-induced repression, though it should 
be noted that co-treatment of PDGF with  1 or  10%  FBS 
resulted  in  an  enhanced  mitogenic  response  (P  <  0.05). 
These results suggest that the differential efficacy of FBS and 
PDGF  in  repressing  alpha  actin  synthesis  cannot  be  ac- 
counted for by a serum inhibitor of PDGF-induced repres- 
sion.  However, due to  inherent limitations in experiments 
involving undefined serum-containing media, these experi- 
ments are not definitive (see Discussion). Thus the effects of 
a possible serum-derived inhibitor, TGF-13, were examined 
in a defined serum-free medium. TGF-13 was selected based 
on the following considerations: TGF-13 is present in serum 
in relatively high concentrations and has been shown to affect 
SMC  growth  (Assoian and Sporn,  1986) and organization 
behavior (Majack, 1987), as well as myoblast differentiation 
(Massague et al.,  1986; Olson et al.,  1986). The results of 
a representative experiment are shown in Table IV. Results 
demonstrated  that  co-treatment  with  TGF-I~ partially  in- 
hibited the mitogenic response for both PDGF (24 %; P  < 
0.05) and FBS (25 %; P < 0.05) but did not significantly affect 
the repression of SM alpha actin synthesis by either mitogen. 
Interestingly, TGF-I~ alone elicited a  25%  increase in the 
fractional synthesis of SM alpha actin. 
Discussion 
It has been established from previous studies that growth ar- 
rest of SMC is associated with induction of SM-specific con- 
tractile proteins (Strauch and Rubenstein,  1984; Owens et 
al., 1986; Rovner et al., 1986). At confluence, SMC exhibit 
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Figure 7. Effect  of FBS on PDGF-induced repression of SM alpha 
actin synthesis (top) and stimulation of S phase entry (bottom). 
Postconfluent SMC  cultures  in  SFM  were  treated  with  FBS 
(0.1-10%) with  and  without  PDGF  (10  ng/ml). Cultures  were 
pulsed with [3H]thymidine and [35S]methionine and harvested as 
described in Fig. 4. Similar results were obtained in a separate inde- 
pendent experiment. (Open circles) FBS +  PDGF vehicle; (solid 
circles) FBS +  PDGE 
contact inhibition of growth and undergo rapid induction of 
SM alpha actin synthesis. Whereas these observations sug- 
gested a causal  relationship between cell cycle withdrawal 
and the induction of SM alpha actin synthesis, results of the 
present study clearly demonstrate that cell cycle withdrawal 
is not a prerequisite for induction of SM alpha actin synthesis 
in cultured SMC at confluency since both definitively cycling 
(S  +  G2) as well as Budr  + cells are induced as compared 
with subconfluent cells. Results suggest an important role for 
cell density or cell-cell contact in control of SM alpha actin 
expression. This is consistent with observations by Strauch 
and Rubenstein (1984)  who found that cell confluence was 
Table IV.  The Effect of TGF-[3 on the Repression of 
Alpha Actin Synthesis and S Phase Entry Induced by 
PDGF and FBS* 
Percent repression 
of alpha actin  Percent 13Hlthymidine - 
Treatment  synthesis*  labeled cells 
SFM  0.00  _+  11.00§  b  4.97  _+  0.37 d 
PDGF  (10  ng/ml)  97.66  +  1.09  a  41.31  _+ 2.47 b 
FBS  (10%)  71.85  _+  4.95 •  49.34  +  0.64" 
TGF-fl  (2.5  ng/ml)  -25.31  _+ 4.92 ~  5.26  -t-  1.34  d 
PDGF  +  TGF-[3  90.37  _+  3.09"  31.58  +  1.46  c 
FBS  +  FGF-[3  86.06  _+  7.39"  37.11  +_  2.58 b 
* Data presented as mean  ___  SEM of one representative experiment.  Actin 
synthesis determinations were performed in duplicate;  [3H]thymidine-labeling 
index in quadruplicate. 
* Expressed as a percentage of appropriate control. 
§ Means with different letter designations are significantly different  (Newman- 
Keuls Test;  P  <  0.05). 
a prerequisite for the induction of alpha actin synthesis in the 
BC3H1 cell line, although BC3H1 cells show an attenuated 
induction of alpha actin synthesis at confluency in the pres- 
ence of serum unlike  rat aortic SMC  used in the present 
studies. 
Though our data indicate that cell cycle withdrawal is not 
a prerequisite for induction of SM alpha actin synthesis at 
confluency, we cannot rule out the possibility that induction 
of SM alpha actin synthesis in cycling cells at confluency is 
a "programmed" event associated with cell cycle withdrawal 
but preceding it by a fixed interval. The finding that induction 
precedes  cell cycle withdrawal  has  precedent since  other 
workers  have  discovered  the  expression  of differentiated 
characteristics in erythroblasts before cell cycle withdrawal 
(Campbell  et al.,  1971). Furthermore,  other studies  have 
demonstrated the association of cell-cell contact at conflu- 
ency with cytodifferentiation  (Rodesch, 1973; Munson et al., 
1982;  Strauch and Rubenstein,  1984;  Owens et al.,  1986). 
However, the present study is to our knowledge the first to 
demonstrate the dissociation of contact inhibition of growth 
from contact-induced cytodifferentiation. 
It should be noted, however, that our data, as well as those 
of Strauch and Rubenstein (1984)  indicate that the growth 
state of SMC is important in the control of cytodifferentia- 
tion. In previous studies we found that induction of SM alpha 
actin also occurs in subconfluent cultures of rat aortic SMC 
subjected to prolonged growth arrest in a defined serum-free 
medium. Furthermore, in these previous studies, the level of 
induction increases with time in association with decreases 
in the fraction of replicating cells. Results of present studies 
indicate that quiescent, postconfluent SMC  in culture can 
initiate  DNA  replication upon stimulation  with mitogenic 
agents (FBS and PDGF), and that mitogenesis is associated 
with marked repression of SM alpha actin synthesis. PDGF 
is an extremely potent repressor of SM alpha actin synthesis, 
with half-maximal repression occurring at picomolar con- 
centrations. 
Interestingly, PDGF was  substantially  more effective in 
repressing SM alpha actin synthesis than was FBS for a given 
level of mitogenic stimulation.  One possibility is that the 
lower potency of serum relative to its mitogenic activity may 
relate to certain as yet unidentified factors present in serum 
which promote differentiation in cultured SMC. The results 
of the present study, however, indicate that one putative fac- 
tor that might have this activity, TGF-13, does not antagonize 
either the PDGF- or FBS-induced repression of alpha actin 
synthesis, though TGF-13 alone elicits a small increase in the 
expression of SM alpha actin synthesis. Furthermore, results 
from FBS-PDGF co-treatment experiments suggest that se- 
rum does not contain an inhibitor of mitogen-induced repres- 
sion in that 0.1-10.0%  FBS failed to inhibit PDGF-induced 
repression. However, these experiments are not definitive in 
this  regard,  largely due  to  inherent limitations of experi- 
ments using serum-containing media. For example, the en- 
hanced mitogenic response observed with FBS (1 or 10%) 
and PDGF, or the high dose of PDGF used, may have ob- 
scured the effects of a putative inhibitor. Alternatively, the 
principal  mitogens  in  FBS  may  simply  be  less  effective 
repressors of alpha actin synthesis than is PDGE A final pos- 
sibility is that PDGF may have been more effective than FBS 
in inducing a Go-Gt transition or "competence state" but not 
as effective in promoting progression to S phase, consistent 
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phokinase by anionic brain FGF in BC3H1 cells does not 
require mitogenesis (Lathrop et al., 1985). If the repression 
of SM alpha actin synthesis after mitogenic stimulation ac- 
companies G0-G~ transition, this might be invoked to ex- 
plain the differential effects of PDGF versus FBS on SM al- 
pha actin synthesis. 
Results of this study suggest that an important action of po- 
tent growth factors such as PDGF may be in the control of 
SM differentiation. The possible function of PDGF in the 
regulation of SM differentiation is suggested by its altered ex- 
pression in developmental and pathological situations. Cul- 
tured SMC derived from young but not old rats express high 
levels of PDGF-Iike mitogens (Seifert et al.,  1984). Walker 
et al. (1986) have reported that the production of a PDGF- 
like mitogen by SMC derived from intimal lesions is fivefold 
that produced by cells derived from normal media. Recently, 
Barrett and Benditt (1987) demonstrated increased sis gene 
transcript levels in human atherosclerotic lesions compared 
with normal arteries which suggests that increased produc- 
tion of the PDGF b-chain by lesion cells may play an impor- 
tant  role  in  atherogenesis.  Clearly,  the  emerging  role  of 
PDGF in the control of SM differentiation warrants further 
investigation of the mechanism by which mitogens regulate 
the expression of SM-specific gene products. 
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